8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 20, 2016

Commission File Number: 0-24260

Amedisys, Inc.

(Exact name of registrant as specified in charter)

Delaware	11-3131700
(State or other jurisdiction	(IRS Employer
of incorporation or organization)	Identification No.)

3854 American Way, Suite A, Baton Rouge, LA 70816

(Address of principal executive offices, including zip code)

(225) 292-2031 or (800) 467-2662

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure.

On October 20, 2016, Amedisys, Inc. (the “Company”) issued a press release announcing that it has closed on the acquisition of Visiting Nurse Association of Long Island (VNALI), a nonprofit organization based in Garden City, New York, a copy of which is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) is being “furnished” and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of Section 18, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Description
99.1	Press Release dated October 20, 2016

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMEDISYS, INC.
By:	/s/ Paul B. Kusserow
Paul B. Kusserow
President and Chief Executive Officer
DATE: October 20, 2016

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press Release dated October 20, 2016

EX-99.1

Exhibit 99.1

	Contact:
	Kendra Kimmons
	Managing Director of Communications
	225-299-3708 kendra.kimmons@amedisys.com
	David Castille
	Managing Director of Finance
	225-299-3665 david.castille@amedisys.com

Amedisys Closes On Visiting Nurse Association of Long Island Acquisition

BATON ROUGE, La., October 20, 2016 – Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home health care and hospice companies, today announced that it has closed on the acquisition of Visiting Nurse Association of Long Island (VNALI), a nonprofit organization based in Garden City, New York that once served more than 100 communities throughout Long Island, Queens, Brooklyn and The Bronx. Amedisys acquired substantially all of the assets of VNALI for $4.6 million.

VNALI, founded in 1915, is one of the nation’s oldest Visiting Nurse Associations. Most recently, the Centers For Medicare & Medicaid Services gave VNALI a rating of four stars out of five in quality of care for Medicare patients. VNALI performed better than average on 18 of 22 measures for quality through both New York State and the United States. The organization filed for bankruptcy in June, 2015.

“VNALI has developed an outstanding reputation for taking care of patients for the past 100 years and this acquisition allows us to continue that care,” stated Amedisys President and Chief Executive Officer Paul Kusserow. “It is also the first time ever that Amedisys has entered New York City, a heavily urban marketplace, and as a result gives us access to Kings and Queens Counties, among the nation’s largest Medicare populations. It also extends our reach in the densely populated Long Island market, where Tender Loving Care, an Amedisys company, operates facilities in Hicksville and Medford.”

The Visiting Nurse Association of Long Island is a federally and state certified home health agency. Until recently, the organization provided valuable health and community-based services to the region. It has served Long Island residents for more than 100 years and is recognized as one of the country’s top 500 healthcare providers. At one time, the agency served 450 to 500 patients per week.

Amedisys will provide further detail during its third quarter 2016 earnings conference call.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000

employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 340,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.

We use our company website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation, Nominating and Corporate Governance, Quality of Care and Compliance and Ethics Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).

#     #     #